Purdue Pharma to present Butrans Transdermal System CIII clinical program data at PAINWeek 2010
Links shared publicly online about this topic.
- 884total visits
Purdue Pharma to present Butrans Transdermal System CIII clinical program data at PAINWeek 2010
Purdue Pharma L.P. will present data from the clinical program for Butrans" (buprenorphine) Transdermal System CIII in a series of posters at PAINWeek®2010, September 8-10 in Las Vegas.
View full resource at news-medical.net
Most Recently Shared on September 10, 2010 at 1:21 pm By:
Purdue Pharma to present Butrans Transdermal System CIII clinical program data at PAINWeek 2010: Purdue Pharma L.P... http://bit.ly/aUtDKu
Purdue Pharma L.P. to Present Data From Clinical Program for Butrans(TM) (buprenorphine) Transdermal System CIII at PAINWeek 2010 - Health News - redOrbit
redorbit.com — “STAMFORD, Conn., Sept. 9 /PRNewswire/ -- Purdue Pharma L.P. will present data from the clinical program for Butrans(TM) (buprenorphine) Transdermal System CIII in a series of posters at PAINWeek 2010, September 8-10 in Las Vegas. Butrans recently received marketing approval from the U.S.” View full resource at redorbit.com
Most Recently Shared on September 9, 2010 at 7:19 pm By:
Purdue Pharma L.P. to Present Data From Clinical Program for Butrans(TM) (buprenorphine) Transdermal System CIII a... http://bit.ly/cAAEEW
Advertisement
